About Drupal 8
Have you ever felt that your website needs to be more personalized, integrated with cutting-edge technology to offer enhanced user experience?
Valuebound is one of those companies, which specifically help organizations in their path to digital transformation. We enhance digital experience for end users with tailored web applications.
Recent releases
|
Best Practices for Drupal Performance Optimization
Performance bottlenecks in Drupal sites can devastate user experience and strain development resources. After optimizing over 200 enterprise Drupal installations, I've identified core practices…
|
Your Complete Guide to Drupal User Experience
User experience design shapes how people interact with websites. For enterprise organizations managing complex digital ecosystems, the stakes are particularly high. A seamless user experience drives…
|
Using Drupal for Digital Transformation
As a Content Marketing Lead, I have often gotten an opportunity to speak with multiple guests. Some of these have been digital transformation experts, or C-suite executives with a responsibility to…
|
Drupal Security Guide: How to Keep Your Drupal Site Secure
Securing your Drupal site is not just a best practice; it’s a necessity. With Drupal powering a significant portion of enterprise websites, safeguarding your site against vulnerabilities is critical…
CASE STUDY
See all our work
How a Top Indian Pharma Brand Boosted HCP Engagement Using Tech-Led Omnichannel Marketing
India’s renowned pharmaceutical company, known for its strong presence in chronic therapy areas, was facing a growing disconnect with its most important audience: healthcare professionals.
How a Leading Indian Pharma Brand Expanded Reach Across Semi-Urban & Rural Regions
A leading pharmaceutical company in India, well known for its OTC presence and deep connection with mass-market audiences, was preparing to launch a public awareness campaign focused on maternal he
Driving Digital Engagement for a Chronic Care Program with Tech-Led Pharma Marketing
A leading pharmaceutical company in India, known for its chronic care drug portfolio, was preparing to launch a support program aimed at patients diagnosed with congestive heart failure (CHF).
